(Q39456275)

12 September 2017

1 reference

title

Intranasal fluticasone propionate. A reappraisal of its pharmacology and clinical efficacy in the treatment of rhinitis (English)

1 reference

12 September 2017

1 reference

Wiseman LR

1

1 reference

PubMed ID

9129872

12 September 2017

Benfield P

series ordinal

2

1 reference

12 September 2017

1 May 1997

1 reference

12 September 2017

1 reference

12 September 2017

53

1 reference

12 September 2017

5

1 reference

12 September 2017

885-907

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199753050-00014

12 September 2017

0 references

cites work

A multicentre study to assess long-term use of fluticasone propionate aqueous nasal spray in comparison with beclomethasone dipropionate aqueous nasal spray in the treatment of perennial rhinitis.

1 reference

12 December 2020

The efficacy and tolerability of fluticasone propionate aqueous nasal spray in children with seasonal allergic rhinitis

1 reference

12 December 2020

Multicenter trial of fluticasone propionate aqueous nasal spray in ragweed allergic rhinitis

1 reference

12 December 2020

The anti-inflammatory profile of fluticasone propionate

1 reference

12 December 2020

Intranasal fluticasone propionate is more effective than terfenadine tablets for seasonal allergic rhinitis

1 reference

12 December 2020

Once daily intranasal fluticasone propionate is effective for perennial allergic rhinitis

1 reference

12 December 2020

Topical glucocorticosteroid (fluticasone propionate) inhibits cells expressing cytokine mRNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis

1 reference

12 December 2020

Seasonal allergic rhinitis. Newer treatment approaches

1 reference

12 December 2020

The human pharmacology of fluticasone propionate

1 reference

12 December 2020

A double-blind comparison of fluticasone propionate aqueous nasal spray, terfenadine tablets and placebo in the treatment of patients with seasonal allergic rhinitis to grass pollen

1 reference

12 December 2020

Prevention of pollen rhinitis symptoms: comparison of fluticasone propionate aqueous nasal spray and disodium cromoglycate aqueous nasal spray. A multicenter, double-blind, double-dummy, parallel-group study

1 reference

12 December 2020

Influence of prolonged treatment with topical corticosteroid (fluticasone propionate) on early and late phase nasal responses and cellular infiltration in the nasal mucosa after allergen challenge

1 reference

12 December 2020

Topical glucocorticoids inhibit activation by allergen in the upper respiratory tract.

1 reference

12 December 2020

A pharmacologic continuum in the treatment of rhinorrhea: the clinician as economist

1 reference

12 December 2020

A comparison of costs and efficacy of intranasal fluticasone propionate and terfenadine tablets for seasonal allergic rhinitis

1 reference

12 December 2020

Fluticasone propionate: an effective alternative treatment for seasonal allergic rhinitis in adults and adolescents

1 reference

12 December 2020

Nasal cytology in patients with allergic rhinitis: effects of intranasal fluticasone propionate

1 reference

12 December 2020

Glucocorticosteroids and rhinitis

1 reference

12 December 2020

Effects of intranasal glucocorticoids on endogenous glucocorticoid peripheral and central function

1 reference

12 December 2020

Effect of Fluticasone propionate Aqueous Nasal Spray Treatment on Platelet Activating Factor and Eicosanoid Production By nasal Mucosa in Patients with A house Dust Mite Allergy

1 reference

12 December 2020

Intranasal fluticasone propionate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in allergic rhinitis

1 reference

12 December 2020

Intranasal fluticasone propionate versus loratadine in the treatment of adolescent patients with seasonal allergic rhinitis

1 reference

12 December 2020

Structure-activity relationships of topically active steroids: the selection of fluticasone propionate

1 reference

12 December 2020

Double-blind comparison of intranasal fluticasone propionate, 200 micrograms, once daily with 200 micrograms twice daily in the treatment of patients with severe seasonal allergic rhinitis to ragweed

1 reference

12 December 2020

Antihistamines and decongestants

1 reference

12 December 2020

The effect of topical fluticasone propionate on intranasal histamine challenge in subjects with perennial allergic rhinitis.

1 reference

12 December 2020

Mode of action of a topical steroid on immediate phase reaction after antigen challenge and nonspecific nasal hyperreactivity in nasal allergy

1 reference

12 December 2020

Fluticasone propionate aqueous nasal spray is safe and effective for children with seasonal allergic rhinitis

1 reference

12 December 2020

A comparison of intranasal and oral flunisolide in the therapy of allergic rhinitis. Evidence for a topical effect

1 reference

12 December 2020

Pharmacokinetics of intravenous fluticasone propionate in healthy subjects

1 reference

12 December 2020

Fluticasone propionate aqueous nasal spray compared with terfenadine tablets in the treatment of seasonal allergic rhinitis

1 reference

12 December 2020

Once daily fluticasone propionate aqueous nasal spray controls symptoms of most patients with seasonal allergic rhinitis

1 reference

12 December 2020

Effect of 3 months' nasal steroid therapy on nasal T cells and Langerhans cells in patients suffering from allergic rhinitis

1 reference

12 December 2020

Placebo-controlled versus comparative studies of drug effects

1 reference

12 December 2020

Interleukin-5 and eosinophil cationic protein in nasal lavages of rhinitis patients

1 reference

12 December 2020

A comparison of budesonide nasal dry powder with fluticasone propionate aqueous nasal spray in patients with perennial allergic rhinitis

1 reference

12 December 2020

Once daily fluticasone propionate aqueous nasal spray is an effective treatment for seasonal allergic rhinitis

1 reference

12 December 2020

Treatment of seasonal allergic rhinitis with once-daily intranasal fluticasone propionate therapy in children. Fluticasone Propionate Collaborative Pediatric Working Group

1 reference

12 December 2020

Effect of intranasal fluticasone proprionate on the immediate and late allergic reaction and nasal hyperreactivity in patients with a house dust mite allergy

1 reference

12 December 2020

Mast cells and mediators in the nasal mucosa after allergen challenge. Effects of four weeks' treatment with topical glucocorticoid

1 reference

12 December 2020

Nasal cytological changes following pharmacological intervention

1 reference

12 December 2020

Further observations on the role of IgE-mediated hypersensitivity in recurrent otitis media with effusion

1 reference

12 December 2020

Economic outcomes for the treatment of allergic rhinitis

1 reference

12 December 2020

A placebo‐controlled study of fluticasone propionate aqueous nasal spray and beclomethasone dipropionate in perennial rhinitis: efficacy in allergic and non‐allergic perennial rhinitis

1 reference

12 December 2020

Costs of hay fever in the United States in 1990.

1 reference

12 December 2020

Prevalence of asthma and hay fever in England and Wales

1 reference

12 December 2020

Effect of short-term treatment with fluticasone propionate nasal spray on the response to nasal allergen challenge

1 reference

12 December 2020

Fluticasone propionate--an update on preclinical and clinical experience

1 reference

12 December 2020

Once daily intranasal fluticasone propionate (200 micrograms) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis

1 reference

12 December 2020

Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: development and testing of a questionnaire for clinical trials.

1 reference

12 December 2020

Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire.

1 reference

12 December 2020

Clinical and physiological effects of fluticasone propionate aqueous nasal spray in the treatment of perennial rhinitis.

1 reference

12 December 2020

Binding kinetics of fluticasone propionate to the human glucocorticoid receptor

1 reference

12 December 2020

Role of antihistamines in allergic disease

1 reference

12 December 2020

Effect of topical corticosteroids on seasonally induced increases in nasal mast cells.

1 reference

12 December 2020

Fluticasone propionate is associated with severe infection after endoscopic polypectomy

1 reference

12 December 2020

Nasal bioavailability and systemic effects of the glucocorticoid budesonide in man

1 reference

12 December 2020

Fluticasone propionate given once daily is as effective for seasonal allergic rhinitis as beclomethasone dipropionate given twice daily

1 reference

12 December 2020

Immunohistology of the nasal mucosa in seasonal allergic rhinitis: increases in activated eosinophils and epithelial mast cells

1 reference

12 December 2020

The effect of fluticasone propionate aqueous nasal spray on nasal mucosal inflammation in perennial allergic rhinitis

1 reference

12 December 2020

Fluticasone propionate aqueous nasal spray: a well-tolerated and effective treatment for children with perennial rhinitis

1 reference

12 December 2020

Effect of the pollen season on nasal mast cells.

1 reference

12 December 2020

Once daily fluticasone propionate is as effective for perennial allergic rhinitis as twice daily beclomethasone diproprionate

1 reference

12 December 2020

10.2165/00003495-199753050-00014

Identifiers

DOI

1 reference

PubMed ID

9129872

Dimensions Publication ID

12 September 2017

0 references

1 reference

PubMed ID

9129872